We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pfizer Healthcare Ireland

9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Medical Information Website: http://www.pfizermedicalinformation.ie
Patient Information Leaflet last updated on medicines.ie: 11/01/2018
PIL Prevenar 13 suspension for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 11/01/2018 and displayed until Current
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
Updated on 19/08/2016 and displayed until 11/01/2018
Reasons for adding or updating:
  • Change to date of revision
Updated on 11/07/2016 and displayed until 19/08/2016
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
Updated on 29/04/2016 and displayed until 11/07/2016
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
Updated on 09/12/2015 and displayed until 29/04/2016
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to MA holder contact details
  • Addition of information on reporting a side effect.
Updated on 17/11/2015 and displayed until 09/12/2015
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 05/05/2015 and displayed until 17/11/2015
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 05/03/2015 and displayed until 05/05/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to date of revision
Updated on 05/03/2015 and displayed until 05/03/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to date of revision
Updated on 22/09/2014 and displayed until 05/03/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 26/08/2014 and displayed until 22/09/2014
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 02/07/2014 and displayed until 26/08/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
Updated on 28/11/2013 and displayed until 02/07/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 22/10/2013 and displayed until 28/11/2013
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
Updated on 12/07/2013 and displayed until 22/10/2013
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
  • Addition of marketing authorisation holder
Updated on 11/01/2013 and displayed until 12/07/2013
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 28/11/2012 and displayed until 11/01/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Improved electronic presentation
Updated on 12/07/2012 and displayed until 28/11/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 29/03/2012 and displayed until 12/07/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 04/11/2011 and displayed until 29/03/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 13/10/2010 and displayed until 04/11/2011
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share